LRI Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

LRI Investments’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63	Buy	+2	New	+$59	﹤0.01%	1892

Other funds holding CPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

CWP

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CNAM

Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return

LRI Investments's CPRX Position: Q2 2026 in Review

LRI Investments opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 2 shares worth $63. The stake represents ﹤0.01% of the portfolio and ranks #1892 among its holdings.

106 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

LRI Investments held 2 shares of Catalyst Pharmaceutical worth $63 as of Q2 2026.
Catalyst Pharmaceutical was a new LRI Investments position in Q2 2026.
Catalyst Pharmaceutical made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1892 holding.
106 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.